NEOANTIGENID Trademark

Trademark Overview


On Wednesday, July 29, 2020, a trademark application was filed for NEOANTIGENID with the United States Patent and Trademark Office. The USPTO has given the NEOANTIGENID trademark a serial number of 90080382. The federal status of this trademark filing is REGISTERED as of Tuesday, June 29, 2021. This trademark is owned by Personalis, Inc.. The NEOANTIGENID trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development

Analysis of cells, amino acids, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
neoantigenid

General Information


Serial Number90080382
Word MarkNEOANTIGENID
Filing DateWednesday, July 29, 2020
Status700 - REGISTERED
Status DateTuesday, June 29, 2021
Registration Number6405467
Registration DateTuesday, June 29, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
Goods and ServicesAnalysis of cells, amino acids, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 27, 2020
Primary Code042
First Use Anywhere DateThursday, February 8, 2018
First Use In Commerce DateThursday, February 8, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 27, 2020
Primary Code044
First Use Anywhere DateThursday, February 8, 2018
First Use In Commerce DateThursday, February 8, 2018

Trademark Owner History


Party NamePersonalis, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NamePersonalis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Tuesday, June 29, 2021REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, May 25, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 25, 2021ASSIGNED TO LIE
Monday, May 24, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, May 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 23, 2020NON-FINAL ACTION E-MAILED
Monday, November 23, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 17, 2020ASSIGNED TO EXAMINER
Thursday, August 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 1, 2020NEW APPLICATION ENTERED IN TRAM